Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor)
Company to Host Investor Webcast Following ESMO Data Presentation on October 22 at 12:30 p.m. Eastern
REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (NASDAQ:https://www.esmo.org/meeting-calendar/esmo-congress-2023.
Investor Webcast
Revolution Medicines will host an investor webcast on Sunday, October 22, 2023, at 12:30 p.m. ET. The presentation will review the clinical data presentations on RMC-6236 and RMC-6291 highlighted above, related clinical development vision, and the company’s overall pipeline and strategy. To participate in the live webcast, participants may register in advance here: https://edge.media-server.com/mmc/p/eb8agxe6. A live webcast of the call will also be available on the Investors section of Revolution Medicines’ website at https://ir.revmed.com/events-and-presentations. Following the live webcast, a replay will be available on the company’s website for at least 14 days.
